Evaluation of High-Dose Isoniazid in Multidrug-Resistant Tuberculosis Treatment
High-dose isoniazid is recommended to treat multidrug-resistant tuberculosis (MDR TB). Among 958 MDR TB isolates identified in France during 2008-2022, 93.1% exhibited high-level isoniazid resistance, and molecular testing showed limited diagnostic accuracy in predicting resistance. Clinicians shoul...
Saved in:
| Published in: | Emerging infectious diseases Vol. 31; no. 3; pp. 633 - 636 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
U.S. National Center for Infectious Diseases
01.03.2025
Centers for Disease Control and Prevention |
| Subjects: | |
| ISSN: | 1080-6040, 1080-6059, 1080-6059 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!